The analysis of Global Hospital Discharges for Dorsalgia Cases indicates notable disparities among countries. In 2023, Germany exhibited the highest number of discharges (296.34 thousand), with a slight year-on-year growth of 0.69%. Switzerland saw a decline of 1.07%, while Chile experienced a 0.67% increase. Israel's discharges slightly decreased by 0.17%, and New Zealand witnessed the most significant rise at 2.23%. Over the past five years, these nations have displayed varying trends, with Germany and New Zealand showing growth and Switzerland and Israel experiencing declines.
Future trends to watch involve technological advancements in dorsalgia treatment, changes in healthcare policies, and demographic shifts impacting demand for hospital services. Additionally, evolving medical practices and public health initiatives aimed at preventing dorsalgia may influence discharge rates across different regions. Economic factors and healthcare infrastructure improvements will also play pivotal roles in shaping these trends globally.
Top countries in Hospital Discharges for Dorsalgia Cases by Country
| # | 5 Countries | Units (Hospital Discharges) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 296,340 | 2023 | +7.16% | +0.69% | View data |
| 2 | 2 Switzerland | 7,520 | 2023 | +1.63% | -1.07% | View data |
| 3 | 3 Chile | 5,480 | 2023 | +7.83% | +0.67% | View data |
| 4 | 4 Israel | 3,430 | 2023 | +4.25% | -0.17% | View data |
| 5 | 5 New Zealand | 3,220 | 2023 | +2% | +2.23% | View data |
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...